18:27 , May 15, 2018 |  BC Innovations  |  Distillery Techniques

Assays and screens; drug delivery

TECHNOLOGY: Binding assays; cellular assays; peptides A phage-based screening method could identify bacteria-binding peptides for species-specific delivery of antimicrobial drug compounds. The method involves using phage display to screen peptide libraries for compounds that bind...
07:00 , Jul 23, 2012 |  BioCentury  |  Emerging Company Profile

Xagenic: PCR-free diagnosis

PCR-based diagnosis of infections can delay treatment decisions by days or hours because the method relies on technical expertise and equipment not available in most point-of-care settings. Xagenic Inc. 's chip-based arrays use a non-PCR,...
07:00 , May 10, 2010 |  BC Week In Review  |  Company News

Genzyme diagnostic, biomanufacturing news

Carl Icahn submitted a proxy statement to the SEC outlining which four of the Genzyme board members - including Chairman, President and CEO Henri Termeer - he hopes to replace with his own slate. Others...
07:00 , Jul 19, 1999 |  BC Week In Review  |  Company News

Chiroscience, MIT deal

CRO received an exclusive worldwide license from MIT to catalysts for asymmetric olefin metathesis, which CRO will develop for use in its chiral products business. Metathesis is a synthetic reaction that forms carbon-carbon bonds between...